title: Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels.
abstract: There are limited data about bone turnover markers (BTM) in androgen deprivation therapy (ADT)-treated prostate cancer (PCa) patients, and the relationship between sex steroids, bone mass, and BTM has not been explored. Our objective was to analyze the influence of sex steroids levels on BTM in patients with PCa treated with or without ADT. We performed a cross-sectional study including 83 subjects with PCa (54% with ADT). BTM, bone mineral density (BMD), and sex steroids were determined. BTM were inversely related to serum level of estrogens. Tartrate-specific acid phosphatase (TRAP-5b) showed a negative correlation with free estradiol (Free E) (r = -0.274, p = 0.014) and Bio E (r = -0.256, p = 0.022) that remained after adjustment for age: Free E (β = -0.241, p = 0.03) and Bio E (β = -0.213, p = 0.063). Bone-specific alkaline phosphatase (BSAP) concentrations were inversely related to Free E (r = -0.281, p = 0.011, age-adjusted β = -0.256, p = 0.024). There was a negative correlation between osteocalcin (OC) levels and Free E (r = -0.195, p = 0.082; age-adjusted β = -0.203, p = 0.076) and Bio E (r = -0.215, p = 0.054; age-adjusted β = -0.240, p = 0.039). BTM and androgens were inversely related to TRAP-5b: total testosterone (total T) (r = -0.238, p = 0.033), Free T (r = -0.309, p = 0.05), and Bio T (r = -0.310, p = 0.05), but these correlations disappeared after age-adjustment. We did not find any relationship between BMD at different locations and sex steroids. In conclusion, in patients with PCa, estrogen levels influence bone resorption and bone formation whereas androgens may exert actions only in bone resorption. These results suggest that estradiol is the main sex steroid that regulates bone metabolism in males with prostate carcinoma.
authors: Bone Metabolic Unit, Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain.
authors: Mariela
authors: M
authors: Varsavsky
authors: Rebeca
authors: R
authors: Reyes-García
authors: Antonia
authors: A
authors: García-Martín
authors: Pedro
authors: P
authors: Rozas-Moreno
authors: Rocío
authors: R
authors: González-Ramírez
authors: González-Ramírez
authors: GR
authors: Rocío
authors: Manuel
authors: M
authors: Muñoz-Torres
mesh_terms: D000368:Aged; D000728:Androgens / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D015519:Bone Density; D016723:Bone Remodeling; D004967:Estrogens / Q000097:blood; D012739:Gonadal Steroid Hormones / Q000097:blood*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D000728:Androgens; D014408:Biomarkers, Tumor; D004967:Estrogens; D012739:Gonadal Steroid Hormones
references: Osteoporos Int. 2008 Mar;19(3):321-7
references: 17906826
references: J Clin Oncol. 2007 Jan 1;25(1):77-84
references: 17194907
references: J Bone Miner Res. 2000 Jul;15(7):1405-11
references: 10893691
references: J Clin Oncol. 2005 Nov 1;23(31):7897-903
references: 16258089
references: J Clin Endocrinol Metab. 2001 Jan;86(1):192-9
references: 11232000
references: J Clin Invest. 2000 Dec;106(12):1553-60
references: 11120762
references: Cancer. 2001 Jun 15;91(12):2238-45
references: 11413511
references: Osteoporos Int. 2013 Feb;24(2):713-9
references: 22588185
references: J Clin Endocrinol Metab. 2002 Aug;87(8):3656-61
references: 12161491
references: J Androl. 2012 Jul-Aug;33(4):594-600
references: 21903971
references: J Clin Endocrinol Metab. 2001 Jun;86(6):2869-74
references: 11397902
references: J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
references: 10523012
references: J Clin Endocrinol Metab. 2006 Apr;91(4):1336-44
references: 16368750
references: J Clin Endocrinol Metab. 2005 Dec;90(12):6410-7
references: 16189261
references: J Clin Endocrinol Metab. 2000 Jan;85(1):219-23
references: 10634390
references: Eur J Endocrinol. 2012 Jun;166(6):983-91
references: 22423144
references: J Clin Endocrinol Metab. 2003 Jan;88(1):204-10
references: 12519853
references: J Steroid Biochem. 1982 Jun;16(6):801-10
references: 7202083
references: J Bone Miner Res. 2008 Oct;23(10):1552-60
references: 18518773
references: N Engl J Med. 2005 Jan 13;352(2):154-64
references: 15647578